Medical News

RSS

Vancomycin beneficial for managing patients hospitalized with cellulits

Patients admitted to the hospital for the common bacterial skin infection cellulitis should be treated as a first line of defense with the potent antibiotic drug vancomycin rather than other antibiotics such as penicillin, according to a Henry Ford Hospital study.

25 Oct 2010

Daschle on health law: Defunding is 'a serious threat'

Tom Daschle, the former Senate Majority Leader and a senior, informal, advisor to President Obama during the health debate has been writing and talking about how the law got passed.

25 Oct 2010

Sinovac Biotech receives Drug Registration Certificate for seasonal influenza vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that Sinovac Biotech (Hong Kong) Ltd., its wholly owned subsidiary company in Hong Kong, has received the Certificate of Drug/Product Registration from the Hong Kong Department of Health for its seasonal influenza vaccine Anflu.

25 Oct 2010

Taste receptors in lungs can revolutionize treatment option for asthma

Taste receptors in the lungs. Researchers at the University of Maryland School of Medicine in Baltimore have discovered that bitter taste receptors are not just located in the mouth but also in human lungs. What they learned about the role of the receptors could revolutionize the treatment of asthma and other obstructive lung diseases.

25 Oct 2010

Researchers discover microglia cells originates prior to birth during embryonic life

Mount Sinai researchers have discovered that microglia, the immune cells that reside in the brain, have a unique origin and are formed shortly after conception. It was previously thought that microglia originated at the same time as macrophages, which are other immune cells that are thought to develop at birth. This groundbreaking discovery has the potential to lead to future treatments of degenerative brain diseases such as Alzheimer's and autoimmune diseases such as multiple sclerosis. The study is published online October 21 in Science Express.

25 Oct 2010

Botox beneficial for cosmetic dental treatment

A significant majority of dental implant patients are older with facial aging and their dentists may need to consider the benefits of rejuvenation techniques, such as Botox, for maximizing the cosmetic outcomes of the procedure, according to a leading cosmetic surgeon speaking at the American Academy of Implant Dentistry annual meeting.

25 Oct 2010

Maven Semantic updates Antiviral research database

Maven Semantic announces updates to their Antiviral research database. The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

25 Oct 2010

WallFlex Biliary RX Stent receives CE Mark approval for benign biliary strictures

Boston Scientific Corporation today announced that its WallFlex Biliary RX Fully Covered Stent has received CE Mark approval for the treatment of benign biliary strictures.

25 Oct 2010

GE Healthcare signs definitive agreement to acquire Clarient

GE Healthcare, a unit of General Electric Company and Clarient, Inc. announced today that they have entered into a definitive agreement for GE Healthcare to acquire Clarient, a leading player in the fast-growing molecular diagnostics sector.

25 Oct 2010

$Cedars-Sinai to develop world's first biological treatment for compression fractures$

Cedars-Sinai to develop world's first biological treatment for compression fractures

A team of physicians and scientists from the Cedars-Sinai Regenerative Medicine Institute and Department of Surgery, led by Dan Gazit, DMD, PhD has been awarded a three-year $1.9 million grant from the California stem cell agency to fund research leading to clinical trials for what could become the first biological treatment for the most common type of bone fracture in osteoporosis patients.

25 Oct 2010

Shrink announces agreement to produce high content screening tool for biotech R&D subsidiary

Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that it has entered into an agreement to produce a high content screening tool for its biotech R&D subsidiary, Shrink Chips LLC.

25 Oct 2010

Optimer presents two fidaxomicin Phase 3 trials data for CDI infection at IDSA Annual Meeting

Optimer Pharmaceuticals, Inc. announced today the presentation of combined data from its two fidaxomicin Phase 3 trials in patients with Clostridium difficile infection (CDI) at the 48th Annual Meeting of the Infectious Disease Society of America (IDSA) in Vancouver, British Columbia, Canada.

25 Oct 2010

Pharmaxis announces combined results of Bronchitol Phase III trial for cystic fibrosis

Pharmaceutical company Pharmaxis today announced significant results of pooled data from its two large scale six month Phase III trials of Bronchitol (inhaled mannitol) in people with cystic fibrosis.

25 Oct 2010

Researchers find evidence that A. gambiae mosquito is evolving into two strains, could present challenges for malaria control efforts

The Anopheles gambiae mosquito, one of the major carriers of the malaria parasite in Sub-Saharan Africa, is evolving in two directions, according to two studies published Thursday in the journal Science, Scientific American's Observations blog reports.

25 Oct 2010

Revance presents results of RT001 two Phase 2b clinical trials for lateral canthal lines at Chicago annual meeting

Revance Therapeutics, Inc. today announced that the results of two Phase 2b clinical trials on RT001, a topical botulinum toxin type A which is under investigation for the treatment of lateral canthal lines (crow's feet wrinkles) were presented at the annual meeting of the American Society of Dermatologic Surgery in Chicago.

25 Oct 2010

FDA issues complete response letter for ViroPharma's Cinryze

ViroPharma Incorporated today announced the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding Cinryze (C1 Esterase Inhibitor [Human]) industrial scale manufacturing expansion activities. The FDA has requested additional information related to observations from the pre-approval inspection and review of the technical processes.

25 Oct 2010

ISTSS to honor Vietnam veteran with Lifetime Achievement Award

Joseph Boscarino, Ph.D, M.P.H.,will be recognized by the International Society of Traumatic Stress (ISTSS) with a Lifetime Achievement Award for his contributions to the research of traumatic stress.

25 Oct 2010

St. Jude Medical authorizes additional share repurchase program

St. Jude Medical, Inc. a global medical device company, today announced that its Board of Directors has authorized an additional share repurchase program of up to $300 million of its outstanding common stock.

25 Oct 2010

Scientists find two proteins that regulates water retention in salt-sensitive hypertension

Research conducted by scientists at LSU Health Sciences Center New Orleans has found that two proteins in the brain act as valves to turn the hormone that regulates water retention in the body on and off. Their findings may lead to advances in treatment for diseases like high blood pressure, congestive heart failure, and cirrhosis of the liver. The research is published in the November 1, 2010 issue of Endocrinology.

25 Oct 2010

Aid agencies threaten to leave Afghanistan as President Karzai orders private security firms to dissolve

Companies and aid organizations implementing hundreds of millions of dollars in U.S.-funded projects here say they are preparing to leave Afghanistan unless President Hamid Karzai amends a decree that outlaws their private security protection, the Wall Street Journal reports.

25 Oct 2010

Medical News

Vancomycin beneficial for managing patients hospitalized with cellulits

Daschle on health law: Defunding is 'a serious threat'

Sinovac Biotech receives Drug Registration Certificate for seasonal influenza vaccine

Taste receptors in lungs can revolutionize treatment option for asthma

Researchers discover microglia cells originates prior to birth during embryonic life

Botox beneficial for cosmetic dental treatment

Maven Semantic updates Antiviral research database

WallFlex Biliary RX Stent receives CE Mark approval for benign biliary strictures

GE Healthcare signs definitive agreement to acquire Clarient

Cedars-Sinai to develop world's first biological treatment for compression fractures

Shrink announces agreement to produce high content screening tool for biotech R&D subsidiary

Optimer presents two fidaxomicin Phase 3 trials data for CDI infection at IDSA Annual Meeting

Pharmaxis announces combined results of Bronchitol Phase III trial for cystic fibrosis

Researchers find evidence that A. gambiae mosquito is evolving into two strains, could present challenges for malaria control efforts

Revance presents results of RT001 two Phase 2b clinical trials for lateral canthal lines at Chicago annual meeting

FDA issues complete response letter for ViroPharma's Cinryze

ISTSS to honor Vietnam veteran with Lifetime Achievement Award

St. Jude Medical authorizes additional share repurchase program

Scientists find two proteins that regulates water retention in salt-sensitive hypertension

Aid agencies threaten to leave Afghanistan as President Karzai orders private security firms to dissolve

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News